Advanced Search
Submit ManuscriptADVANCE ONLINE PUBLICATION
Persistent in vivo epigenetic silencing of Pcsk9
Isabella R. Gengaro1,2 , Lei S. Qi2,3,4,*
1Department of Chemical Engineering, Stanford University, Stanford, CA, USAThe quest for safer therapeutic alternatives to genome editing heralds epigenome editing as a promising approach. In a recent study published in Nature, Cappelluti et al. demonstrated robust, long-term Pcsk9 silencing in vivo with a single administration of epigenetic effectors delivered by lipid nanoparticles, marking a significant stride towards the clinic for epigenetic editing therapies.
https://doi.org/10.1038/s41422-024-00954-z